Now that hepatitis C is highly curable in the DAA era, a greater focus is shifting towards non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. We discussed this further with Jagpreet...
A recent study that was awarded an honorable mention at the 2018 AAD Annual Meeting identified numerous healthcare and demographic disparities in hospital readmissions for skin disease. We spoke with lead...
Katrina Trivers, PhD, MSPH, from the CDC, answered our questions about her new study, which found that nearly 1 in 11 students in the United States had tried cannabis in e-cigarettes in 2016.
Considering pharmacotherapy for your patient with obesity? Here’s what you should know, according to Harold Bays, MD, who presented “Current and Future of Obesity Drug Therapies: Echoes of Today’s Metabolic...
“Primary care providers are increasingly called upon to recognize and treat heart failure early in their patients”, said Keith C. Ferdinand, MD, during his presentation at CRS 2018, “Update in the...
Daniel Blumberger, MD, MSc, from the Centre for Addiction and Mental Health in Canada shares the ins and outs of intermittent theta burst stimulation—the shortened brain stimulation protocol newly approved...
Traumatic brain injuries of all degrees of severity are likely associated with an elevated suicide risk vs no TBI, according to a large-scale Danish cohort study. Consultant360 discussed the study’s key...
Ruchi S Gupta, MD, MPH, Christopher M Warren, PhD(c), and Justin Zaslavsky answer our questions about barriers to epinephrine use and strategies to increase daily carriage and use of auto-injectors in...
Aladdin H. Shadyab, PhD, MS, MPH, CPH, from the University of California, San Diego, answers our questions about his recently published study about how physical activity impacts patients who have undergone...
